-
of theranostic radioligands targeting tumor-associated proteases. Project overview: The Radiopharmacy group has extensive expertise in the development of radiolabeled ligands for proteases implicated in human
-
-associated proteases. Project overview: The Radiopharmacy group has extensive expertise in the development of radiolabeled ligands for proteases implicated in human diseases, with applications in molecular
Searches related to associate bioinformatics
Enter an email to receive alerts for associate-bioinformatics positions